{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:46:04Z","timestamp":1790271964317,"version":"4.1.0"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Little is known about the relative effectiveness of nicotine-containing electronic cigarettes (ECs) compared with varenicline as smoking cessation aids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the relative effectiveness of ECs in smoking cessation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This randomized placebo-controlled single-center trial was conducted in northern Finland. Participants aged 25 to 75 years who smoked daily and had volunteered to quit smoking were recruited from August 1, 2018, to February 20, 2020, via local media. The trial included 52 weeks of follow-up. All data analyses were conducted from September 1, 2022, to January 15, 2024. The participants, study nurses, and researchers were masked to group assignment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>The participants were assigned by block randomization to receive 18 mg\/mL of nicotine-containing ECs together with placebo tablets, varenicline with standard dosing together with nicotine-free ECs, or placebo tablets together with nicotine-free ECs, all combined with a motivational interview, with the intervention phase lasting for 12 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome and Measure<\/jats:title><jats:p>The primary outcome was self-reported 7-day conventional cigarette smoking abstinence as confirmed by the exhaled carbon monoxide level on week 26. The analysis followed the intent-to-treat principle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 561 recruited participants, 458 (81.6%) eligible participants (257 women [56%]; 201 men [44%]; mean [SD] age, 51 [11.6] years) were randomized. The primary outcome occurred in 61 of 152 participants (40.4%) in the EC group, 67 of 153 (43.8%) in the varenicline group, and 30 of 153 (19.7%) in the placebo group (<jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). In the pairwise comparison, placebo differed statistically significantly from ECs (risk difference [RD], 20.7%; 95% CI, 10.4-30.4; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and varenicline (RD, 24.1%; 95% CI, 13.7-33.7; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), but the difference was statistically insignificant between ECs and varenicline (RD, 3.4%; 95% CI, \u22127.6 to 14.3; <jats:italic>P<\/jats:italic>\u2009=\u2009.56). No serious adverse events were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This randomized clinical trial found that varenicline and nicotine-containing ECs were both effective in helping individuals in quitting smoking conventional cigarettes for up to 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03235505\">NCT03235505<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2024.1822","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T15:34:26Z","timestamp":1718638466000},"page":"915","source":"Crossref","is-referenced-by-count":19,"title":["Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults"],"prefix":"10.1001","volume":"184","author":[{"given":"Anna","family":"Tuisku","sequence":"first","affiliation":[{"name":"Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Rahkola","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oulu and Department of Internal Medicine Division Oulu University Hospital, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"Nieminen","sequence":"additional","affiliation":[{"name":"Medical Informatics and Data Analysis Research Group, University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Toljamo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"ioi240033r1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/2042098614524430","article-title":"Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.","volume":"5","author":"Farsalinos","year":"2014","journal-title":"Ther Adv Drug Saf"},{"issue":"8","key":"ioi240033r2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamapediatrics.2017.1488","article-title":"Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults a systematic review and meta-analysis.","volume":"171","author":"Soneji","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"ioi240033r3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2105\/AJPH.2020.305999","article-title":"E-cigarette use and adult cigarette smoking cessation: a meta-analysis.","volume":"111","author":"Wang","year":"2021","journal-title":"Am J Public Health"},{"issue":"1","key":"ioi240033r4","article-title":"Electronic cigarettes for smoking cessation.","volume":"1","author":"Lindson","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ioi240033r5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00428-020-02943-0","article-title":"Vaping-related lung injury.","volume":"478","author":"Smith","year":"2021","journal-title":"Virchows Arch"},{"issue":"15","key":"ioi240033r6","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.3390\/ijerph19159054","article-title":"Health effects of electronic cigarettes: an umbrella review and methodological considerations.","volume":"19","author":"Travis","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"ioi240033r7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/07853890.2015.1045551","article-title":"Clinical characteristics of COPD syndrome: a 6-year follow-up study of adult smokers.","volume":"47","author":"Toljamo","year":"2015","journal-title":"Ann Med"},{"issue":"9","key":"ioi240033r8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/add.1991.86.issue-9","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire.","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"7","key":"ioi240033r9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/add.1989.84.issue-7","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day.","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br J Addict"},{"issue":"12","key":"ioi240033r10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1046\/j.1360-0443.2001.961217253.x","article-title":"The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review.","volume":"96","author":"Dunn","year":"2001","journal-title":"Addiction"},{"issue":"1","key":"ioi240033r11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations.","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"ioi240033r12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.chest.2017.11.002","article-title":"Use of expired air carbon monoxide testing in clinical tobacco treatment settings.","volume":"153","author":"Goldstein","year":"2018","journal-title":"Chest"},{"issue":"1","key":"ioi240033r14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"5","key":"ioi240033r16","article-title":"Nicotine receptor partial agonists for smoking cessation.","volume":"5","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ioi240033r17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial.","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"10037","key":"ioi240033r18","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"ioi240033r19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa2308815","article-title":"Electronic nicotine-delivery systems for smoking cessation.","volume":"390","author":"Auer","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"ioi240033r20","article-title":"Motivational interviewing for smoking cessation.","volume":"7","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ioi240033r15","volume-title":"Statistics with Confidence: Confidence Intervals and Statistical Guidelines","author":"Altman","year":"2000","edition":"2nd ed"},{"key":"ioi240033r13","unstructured":"US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Table for grading the severity of adult and pediatric adverse events, corrected version 2.1. Accessed March 27, 2023. https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2820176\/jamainternal_tuisku_2024_oi_240033_1722366166.8401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T16:14:08Z","timestamp":1722874448000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2820176"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.1822","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}